Millipore Introduces New Tools
for Epithelial Cell Studies

Improved epithelial cell cultures exhibit better growth, morphology, and viability
Billerica, Massachusetts—July 6, 2010—Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today introduced its family of EpiGRO™ epithelial cells and culture media.

EpiGRO products have been optimized to provide improved cell culture for critical research applications. The breakdown of control mechanisms in epithelial cells is a frequent contributor to cancer progression and metastasis. Epithelial cell cultures are also commonly used in respiratory and dermatological research.

Each EpiGRO medium is uniquely formulated to provide an optimized environment for its corresponding EpiGRO cell type. Consequently, cells proliferate faster, exhibit improved morphology, and show better viability than epithelial cells cultured in other media formulations.

The media are provided in unique, light-blocking, temperature-monitored packaging to ensure stability and protect the media from damage by light and contamination.
The family of EpiGRO cell types includes keratinocytes, small airway epithelial cells, corneal cells, and prostate epithelial cells. “We continue to move aggressively to bring innovation and productivity enhancements to the life science research market,” said John Sweeney, Vice President of Millipore’s Life Science business. “With the introduction of the Scepter instrument, we now have a range of tools that help life scientists simplify tedious, repetitive tasks and improve the reproducibility of their experiments.”


Additional Resources
www.millipore.com/epithelial

Download High Resolution Image
Click here to download image.

---

About Millipore
Millipore (NYSE: MIL) is a life science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees worldwide. For more information, visit www.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER^®
Research. Development. Production.


Millipore Contact Information

Trade Media:
Greg Hoff
Bioscience Division
978-762-5170
greg_hoff@millipore.com